Table 1

Demographic and laboratory characteristics of all patients

Age (years)51±12
Gender (male)88 (61%)
BMI (kg/m2)35±5
BMI category
 Lean (<25)1 (1%)
 Overweight (25–29.9)17 (12%)
 Obese (>29.9)127 (87%)
Diabetes73 (50.3%)
Waist circumference (cm)112±11
ALT (IU/l)94±63
AST (IU/l)63±44
GGT (IU/l)148±204
ALB (g/l)44±5
Platelets (×109/litre)255±91
Cholesterol (mmol/l)5.4±1.4
Triglycerides (mmol/l)2.7±2.2
Fibrosis stage (Kleiner)
 037 (25%)
 162 (43%)
 219 (13%)
 314 (10%)
 413 (9%)
Simple steatosis/NASH52 (36%)/93 (64%)
Liver biopsy length (mm)22±8
APRI0.7±0.5
AST/ALT ratio0.73±0.3
BARD score*2 (0–4)
0/1/2/3/4 (n)5/50/45/18/27
FIB-4 score1.54±1.19
NAFLD score−1.47±1.73
  • Mean±SD.

  • * Median and range.

  • ALB, albumin; ALT, alanine aminotransferase; APRI, AST-to-platelet ratio index; AST, aspartate aminotransferase; BMI, body mass index; GGT, gamma-glutamyl transferase; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis.